New Mexico Draws a Clear Line: Federal Rescheduling Does Not Rewrite State Cannabis Rules

While some states have challenged, delayed, or insulated themselves from the federal marijuana rescheduling order, New Mexico has chosen a different approach. In Industry Bulletin 26-07, issued June 16, 2026, the Cannabis Control Division made clear that the federal Schedule III order does not automatically alter New Mexico’s cannabis laws or the obligations of state licensees.¹

The bulletin addresses the April 2026 Department of Justice order that moved certain FDA-approved marijuana products and state-licensed medical cannabis into Schedule III of the Controlled Substances Act. It also notes the parallel administrative proceedings on broader rescheduling. Despite those federal developments, the Division states that New Mexico’s Cannabis Regulation Act, the Lynn and Erin Compassionate Use Act, and all implementing rules remain fully in effect and unchanged.²

Licensees are directed to continue operating under existing state requirements for licensing, packaging, labeling, testing, transportation, and enforcement. The bulletin is explicit: federal actions related to rescheduling “do not automatically modify” those state obligations.³

Like other recent state guidance, New Mexico’s bulletin reinforces an important principle of federalism: amendments to the federal Controlled Substances Act do not, by themselves, alter state cannabis regulatory programs unless state law expressly incorporates or otherwise gives effect to those federal changes.

A Deliberate Choice Against Automatic Conformity

This position is significant because it rejects any assumption that federal scheduling changes flow automatically into state regulatory systems. Some states maintain conformity or trigger language that ties state controlled-substance schedules to federal decisions. Others have begun taking affirmative steps to prevent or delay such effects.

Wyoming’s Attorney General formally blocked automatic state-level rescheduling, keeping marijuana in Schedule I under state law.⁴ Tennessee enacted legislation to prevent an automatic review that could have opened medical cannabis access.⁵ Alabama’s public health authority objected on the grounds that it needed more time to assess implementation.⁶ Nebraska and Indiana joined litigation in the D.C. Circuit challenging the federal order itself.⁷

New Mexico has taken a different path. Rather than litigating or legislating an immediate block, its regulators simply declared that the federal change does not rewrite state law. The result is regulatory continuity for operators and a clear signal that any future adjustments will require deliberate state action.

The Open Question on Interstate Commerce

Unlike the Division’s unequivocal statement that federal rescheduling leaves existing licensing requirements unchanged, the agency deliberately declined to interpret New Mexico’s interstate commerce provisions. The relevant statutes address the possibility of cross-border cannabis activity under certain conditions.⁸ By withholding guidance, regulators preserved flexibility while avoiding premature conclusions about how federal rescheduling, future DEA regulations, or congressional action could affect those provisions.

That distinction is important because the Division addressed present licensing obligations while intentionally leaving future interstate commerce questions unresolved. For now, the agency has declined to activate or interpret the relevant sections, preserving the status quo while leaving the door open for later administrative or legislative clarification.

Why the Bulletin Matters

In the current environment, clarity itself is valuable. Operators in many states are navigating uncertainty about whether federal Schedule III status alters licensing standards, security requirements, testing protocols, or the legal status of products already in the market. New Mexico has reduced that uncertainty by stating, in plain terms, that its rules remain the rules until the state decides otherwise.

The bulletin also illustrates a broader pattern. Some states are actively resisting federal changes, while others are evaluating whether existing trigger or conformity provisions should remain in place. A smaller number, like New Mexico, are issuing formal guidance that preserves state control while federal processes continue.

As more states interpret the federal Schedule III order, the emerging picture is not one of nationwide uniformity but of state-by-state constitutional and statutory analysis. New Mexico’s bulletin demonstrates that rescheduling does not automatically displace state cannabis regulation. Instead, each state must determine—through its own statutes, regulations, and administrative decisions—whether and how federal changes should affect its existing cannabis framework. As additional states publish guidance, these interpretations will likely become an important body of state regulatory analysis explaining how federal rescheduling interacts with existing cannabis programs.

Footnotes

¹ New Mexico Regulation and Licensing Department, Cannabis Control Division, Industry Bulletin 26-07, Updates on Federal Rescheduling of Cannabis (June 16, 2026).

² Id.

³ Id.

⁴ Wyoming Attorney General, Final Decision on Federal Marijuana Rescheduling (July 2026); see also Marijuana Moment, “Wyoming Attorney General Blocks State Marijuana Rescheduling That Would Be Triggered By Trump’s Federal Reform” (July 8, 2026), https://www.marijuanamoment.net/wyoming-attorney-general-blocks-state-marijuana-rescheduling-that-would-be-triggered-by-trumps-federal-reform/.

⁵ Legislation signed by Tennessee Governor Bill Lee blocking automatic review following federal rescheduling (2026 legislative session). https://www.marijuanamoment.net/tennessee-governor-signs-bill-blocking-state-medical-marijuana-legalization-review-following-federal-rescheduling/

⁶ Alabama Department of Public Health vote objecting to federal rescheduling (May 2026).

⁷ Petition for Review, Nebraska, Indiana, and Louisiana v. Department of Justice, No. 26-1130 (D.C. Cir. filed May 22, 2026). Louisiana subsequently dismissed its petition.

⁸ NMSA 1978, §§ 26-2C-37 and 26-2C-38.